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Normal Numbers of Stem Cell
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Reduced Naive T Cells Support
Intact Memory T Cell Compartment
in Ataxia Telangiectasia
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Corry M. R. Weemaes2, Marco W. Schilham1† and Mirjam van der Burg1*†
1 Laboratory for Pediatric Immunology, Department of Pediatrics, Willem-Alexander Children’s Hospital, Leiden University
Medical Center, Leiden, Netherlands, 2 Department of Pediatrics, Radboudumc Amalia Children’s Hospital, Radboud
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Ataxia Telangiectasia (AT) is a rare inherited disorder characterized by progressive
cerebellar ataxia, chromosomal instability, cancer susceptibility and immunodeficiency.
AT is caused by mutations in the ATM gene, which is involved in multiple processes linked
to DNA double strand break repair. Immunologically, ATM mutations lead to hampered V
(D)J recombination and consequently reduced numbers of naive B and T cells. In addition,
class switch recombination is disturbed resulting in antibody deficiency causing common,
mostly sinopulmonary, bacterial infections. Yet, AT patients in general have no clinical T
cell associated infections and numbers of memory T cells are usually normal. In this study
we investigated the naive and memory T cell compartment in five patients with classical AT
and compared them with five healthy controls using a 24-color antibody panel and
spectral flow cytometry. Multidimensional analysis of CD4 and CD8 TCRab+ cells revealed
that early naive T cell populations, i.e. CD4+CD31+ recent thymic emigrants and
CD8+CCR7++CD45RA++ T cells, were strongly reduced in AT patients. However, we
identified normal numbers of stem cell memory T cells expressing CD95, which are
antigen-experienced T cells that can persist for decades because of their self-renewal
capacity. We hypothesize that the presence of stem cell memory T cells explains why AT
patients have an intact memory T cell compartment. In line with this novel finding, memory
T cells of AT patients were normal in number and expressed chemokine receptors,
activating and inhibitory receptors in comparable percentages as controls. Comparing
memory T cell phenotypes by Boolean gating revealed similar diversity indices in AT
compared to controls. We conclude that AT patients have a fully developed memory T cell
compartment despite strongly reduced naive T cells. This could be explained by the
presence of normal numbers of stem cell memory T cells in the naive T cell compartment,
which support the maintenance of the memory T cells. The identification of stem cell
memory T cells via our spectral flow cytometric approach is highly relevant for better
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understanding of T cell immunity in AT. Moreover, it provides possibilities for further
research on this recently identified T cell population in other inborn errors of immunity.
Keywords: Ataxia Telangiectasia, cellular immunity, stem cell memory T cells, spectral flow cytometry, recent
thymic emigrants
INTRODUCTION
Ataxia Telangiectasia (AT) is a rare autosomal recessive
disease characterized by cerebellar ataxia and progressive
neurodegeneration, telangiectasia of the skin and eye,
susceptibility to ionizing radiation (IR), predisposition to
cancer, mostly of lymphoid origin and immunodeficiency (1,
2). The laboratory findings associated with immunodeficiency in
AT are highly variable, even in family members carrying the same
mutation (3, 4). Around two-thirds of patients present with
abnormalities in the immune system, most commonly T and B
cell lymphopenia and immunoglobulin IgG2, IgG4 and IgA
deficiency (1, 5). Some patients present with elevated IgM and
can be wrongly diagnosed as Hyper-IgM syndrome (6). AT has an
estimated prevalence of <1-9/100,000 and an incidence of
between 1 in 20,000 -100,000 live births (1).
The classification of AT is based on absence of the affected
Ataxia Telangiectasia Mutated (ATM) protein and/or its kinase
activity: patients without ATM protein or kinase activity present
as classic AT with (early) childhood onset. Patients with variant
AT have ATM protein with residual activity resulting in a milder
form of the disease, often with adult onset (1). ATM is often
dubbed the master regulator of DNA double stranded break
(DSB) repair. ATM is recruited to DSBs, where it is activated
and subsequently phosphorylates its downstream signaling
targets (1, 2). Through its diverse and vast substrate library
ATM influences many cellular processes, most importantly
DNA DSB repair, cell cycle regulation, apoptosis and cellular
senescence, but also mitochondrial and oxidative stress responses
(2). In the adaptive immune system, ATM is involved in
generation of the B-cell receptor (BCR) and T-cell receptor
(TCR) repertoire via its supportive role in V(D)J recombination
(7, 8). In addition, ATM facilitates Class Switch Recombination
(CSR) in B cells (9, 10). Both V(D)J recombination and CSR are
mediated by DNA DSBs.
The immunodeficiency in AT patients most often presents as
humora l immunodefic iency with common, most ly
sinopulmonary, bacterial infections (5). This has been
attributed to the disturbed generation of naive B cells, resulting
in low numbers and reduced immune repertoire diversity in
naive B cells leading to suboptimal B-cell responses and antibody
deficiency because of suboptimal CSR (2, 11). It is remarkable
that despite these deficits, also in T cell numbers, even the early
onset Classic AT patients do, in general, not suffer from severe
systemic viral disease or opportunistic diseases (5), such as
Pneumocystis jirovecii pneumonia, which are characteristic for
cellular immunodeficiencies.
AT patients have a profound lack of naive cells and a reduced,
skewed TCR beta repertoire when analyzed in total CD4 and
CD8 T cells due to a disturbed generation in the thymus (11–13).
The thymic tissue is usually hypoplastic, with reduced
lymphocytes and lacking Hassall corpuscles (14). The number
of CD31+ recent thymic emigrants (RTEs) (15) is strongly
decreased as are the TCR excision circles (TRECs) (12, 16). In
part of the AT patients the measured TREC levels are very low,
resulting in identification of AT patients as incidental finding in
newborn screening for Severe Combined Immunodeficiencies
(SCID) (17), which is based on quantification of TRECs on dried
blood spots (18). However, despite the strongly reduced counts
of the naive T cell compartment, the memory T cell
compartment seems to be normal in size (11, 12).
The aim of this study is to gain more insight into the T cell
immunity in AT. We aim to tackle the question of why the
reduced number of total, and severely reduced number of naive
T cells, does not lead to opportunistic diseases in the vast
majority of AT patients. In this article, we present our findings
obtained through 24-marker spectral flow cytometry of T cells in
classical AT followed by dimensionality reduction analyses. By
separately, hierarchically analyzing the naive and memory
T cells, we demonstrated that the memory T cell compartment
of AT patients is not only normal in size, but also has an
immunophenotype fully comparable with healthy controls.
Detailed analysis of the naive CCR7+CD45RA+ population
revealed that naive T cells with a stem cell memory phenotype
(CD95+) are present in similar numbers as in control samples.
The combined results suggest that the limited naive T cell
population is sufficient to build up and maintain a functional
memory T cell population.
MATERIALS & METHODS
Patients
Peripheral blood samples and clinical data were collected from 5
classic AT patients, who are under follow up at the Radboud
University Medical Center (Table S1). Ethical approval was
obtained from the Ethical Committee Arnhem/Nijmegen with
protocol registration number 2011/304. Written informed
consent was obtained from all patients. Five healthy control
subjects were also included in our study (B17.001). Leukocyte
subsets (absolute leukocyte counts and differential) were
measured by using a Sysmex hematology analyzer and
Trucount tubes (Becton Dickinson (BD), Franklin Lakes, NJ,
USA) with a mixture of antibodies specific for lymphocyte
subsets in freshly collected blood samples. Antibodies included
CD45 (2D1, BD), CD3 (SK7; BD), CD19 (J4-119, Beckman
Coulter, Brea, CA, USA), CD16 (3G8, BD) and CD56(C5.9,
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DAKO, Glostrup, Denmark). Samples were measured on a BD
CANTO flow cytometer and analyzed with BD DIVA software.
Peripheral blood mononuclear cells (PBMCs) were isolated using
Ficoll density gradient centrifugation and cryo-stored before use.
Spectral Flow Cytometry
PBMCs were phenotyped using a 24-marker spectral flow
cytometry panel (Figure 1A and Table S2). Frozen PBMCs
were thawed using AIM-V medium (Thermo Fisher Scientific,
Waltham, Massachusetts, United States) supplemented with 100
IU/mL Pencillin, 100 mg/mL Streptomycin and 20% heat
inactivated fetal calf serum (thawing medium) supplemented
with DNAse (1600 IU per mL (Thermo Fisher Scientific)) and
incubated for 5 minutes at 37°C. PBMCs were washed twice and
subsequently incubated for one hour at 37°C in thawing
medium. Cells were washed twice in FACS buffer (PBS
supplemented with 0.5% BSA, 2 mM EDTA and 0.02% NaN3)
and counted. One million PBMCs per sample were incubated in
the dark for 45 minutes at room temperature with fluorochrome-




FIGURE 1 | Gating Strategy and T-cell composition in AT patients and controls. (A) Overview of the included markers in the antibody panel for spectral
flowcytometry grouped per category. (B) Gating strategy for T cells. From left to right: live cells; singlets based on forward scatter; singlets based on side scatter;
CD3+ and low side scatter T cells; TCRgd+ T cells; CD4+ and CD8+ T cells; and finally naive, central memory (CM), effector memory (EM) and terminally differentiated
effector memory cell (EMRA) gates within the CD4 and CD8 T cells based on CCR7 and CD45RA expression. (C) Absolute counts of naive, CM, EM and EMRA T
cells within the CD4 (left) and CD8 (right) T cells, visualized in bar graphs (median) and individual closed circles of the classic AT (red) and controls (green). Bottom:
Pie charts of the percentages of naive, CM, EM and EMRA T cells within the classic AT patients and controls. * means P < 0.05, and ** means P ≤ 0.01.
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(BD) in FACS buffer. Next, the cells were washed twice in FACS
buffer and resuspended in a final volume of 100 µL. 7-AAD was
added to the cell suspension 5 minutes prior to sample
acquisition. Flow cytometry was performed with a 5-Laser
Cytek Aurora flow cytometer (Aurora 5L-1, Cytek®
Biosciences Inc, Fremont, California, United States) at the
Flow cytometry Core Facility (FCF) of the Leiden University
Medical Center (LUMC). The measurements and spectral
unmixing were performed using the Spectroflo®Software
(Cytek Biosciences Inc.).
Data Analysis
Data analysis was performed on the unmixed FCS files using the
cytometry analysis platform OMIQ (Omiq, Inc, Santa Clara, CA,
USA). Data were manually compensated and arcsinh
transformed, as previously described (19). Technical variation
was minimized by performing the complete experiment on one
day. Live single cells were gated based on forward scatters, side
scatters and absence of 7-AAD (Figure 1B). To remove
anomalous events, flowAI (20) was applied based on the flow
rate and dynamic range of the fluorochrome parameters. A
maximum of 4.1% events of total live single cells was removed.
Next, the T cells were selected by gating for low side scatter CD3+
events (Figure 1B) and further separated in TCRab+ and
TCRgd+ cells (Figure 1B). CD4+ and CD8+ T cells were gated
from TCRab cells and further divided into naive and non-naive
(memory) cells (Figure 1B). These latter four populations were
used as input for either Uniform Manifold Approximation and
Projection (UMAP) (21) or optimized Stochastic Neighbor
Embedding (Opt-SNE) (22). Downsampling was performed for
the CD4 and CD8memory T cell subsets of all samples to include
an equal number of cells per sample. For the CD4 and CD8 naive
T cells only control samples were downsampled to equal
numbers while all naive cells from patients were included due
to the low numbers. Both opt-SNE and UMAP were calculated
based on all fluorochrome parameters, except 7-AAD. Standard
settings were used, except the minimum distance was set at 0.4
for UMAP. The inversed Simpson index (1/Dominance) (23)
was calculated based on the frequencies of distinct phenotypes
using the abdiv package in R(v3.6.3, R Foundation for Statistical
Computing, Vienna, Austria). To identify the different
phenotypes, Boolean gating was performed by using FlowType
in R, based on the following markers: CD27, CD28, DNAM1,
CD57, CD244, CD56, PD1, CD160, TIGIT, NKG2A, CCR6,
CXCR3, CCR7 and CD25.
Statistical Analysis
Visualizations and statistical analyses were performed in either
Graphpad Prism v8.4.2 (GraphPad Software, California, United
States) or R. Continuous outcome measures were compared
between two groups using multiple unpaired-t testing. The
Holm-Sidak correction was applied to correct for multiple
testing. Statistical significance was set as an adjusted p-value
of <0.05.
RESULTS
Naive T Cells Are Severely Diminished in
AT But Memory T Cells Are Not
In this study we included 5 classic AT patients (age range: 15-24
years), of which 2 did not express ATM protein, while the other 3
expressed ATM protein without kinase activity (Table S1). The
clinical characteristics, including immunoglobulin levels,
infectious episodes, intravenous immunoglobulin (IVIG)
substitution treatment and vaccination responses of the AT
patients are also summarized in Table S1. Of the five patients,
only AT1 received IVIG substitution. Notably, patients AT1 and
AT5, those who completely lack ATM protein, were more
susceptible to bacterial infections. The age range of the 5
healthy controls was between 9-59 years. The absolute
numbers of T cells of all samples, both CD4 and CD8, were
within normal range (Table S1, Figure S1). The only exception
was AT sample 5, where total and CD8+ T cell numbers were
above the normal reference range. A high variety in absolute
numbers of TCRgd+ T cells was observed in both control and
patient samples (Figure S1 and Table S1). The absolute numbers
of B cells and NK cells were normal in the patients, except for
patient 1 with decreased B cells. The subpopulations of NK cells
CD56bright, CD56dimCD16+ and CD56dimCD16- were equally
distributed between patients and controls (Table S1 and
Figure S2).
For the spectral flow cytometry, PBMCs were stained with 24
monoclonal antibodies (Figure 1A and Table S2). First, live
single CD3+ T cells events were gated (Figure 1B). Based on the
CD4 and CD8 staining of the CD3+TCRgd- cells, the CD4+ T
cells were gated allowing for CD4+ T cells expressing low levels
of CD8. CD8+ T cells were gated to include CD4+CD8+ T cells
(Figure 1B). CD4+ and CD8+ T cell populations were
individually subsampled for downstream analysis and will
hereafter be referred to as the CD4 and the CD8 T cells.
Within both the CD4 and CD8 populations of T cells, we
further defined the naive, central memory (CM), effector
memory (EM) and terminally differentiated effector memory
(EMRA) T cells based on CD45RA and CCR7 expression
(Figure 1B). In line with previous literature, patients had
severely diminished naive CD4 and CD8 T cell numbers
(Figure 1C), whereas the sizes of the memory subsets were
comparable to the controls (Figure 1C). This also resulted in a
proportional shift towards the memory cells at the expense of the
naive T cells (Figure 1C; pie charts).
Atypical Dominant CD45RAdimCCR7+
Populations Identified in Two AT Patients
A large proportion of the T cells from patients AT1 and AT5 was
characterized by an abnormal phenotype based on the expression
pattern of CD45RA and CCR7. This population was present in
addition to the classical naive, CM, EM and EMRA T cells. In AT1
this population comprised 86% of CD4 T cells, and in AT5 this
population represented 76% of the CD8 T cells (Figures 2A, B).
The fact that the highest total CD4 T cell number of all patients
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was observed in AT1 (1026 x 106 cells/L) and the highest total CD8
T cell number was observed in AT5 (1523 x 106 cells/L) highlights
the abundancy of these cells (Table S1). Further exploration of the
phenotype of these populations led us to conclude that the
majority of the markers on both the CD4 and CD8 CD45RAdim
populations were homogenously expressed (Figures S3 and S4). A
heterogenous expression of CD31, CD95 and CXCR3 on a minor
fraction of the cells was observed (Figures S3 and S4). The
CD45RAdimCCR7+CD27+CD28+ phenotype combined with the
absence of exhaustion or activation markers suggests that these
cells are phenotypically positioned between the naive and CM
population (Figures 2C, D). While the presence of a dominant
population may be of relevance for further characterization of AT
patients, we decided to exclude these abnormal populations from
further analysis of the CD4 and CD8 T cell populations.
Normal Numbers of Stem Cell Memory
Cells in the Naive T Cell Compartment
of AT Patients
Because the numbers of naive T cells in AT patients were severely
diminished, the composition and phenotype of the remaining
naive T cells were further explored. First, we characterized the
naive CD4 T cells. To visualize the high-dimensional data in 2
dimensions, the dimensionality reduction algorithm UMAP was
applied, based on all fluorochrome parameters (Figure 3A).
UMAP has the advantage that it can reveal potential
differentiation patterns, since cells that are more similar to
each other are closer together and dissimilar cells are further
away from each other.
Although the total number of CD4 naive T cells included in
this analysis from patients was much lower (72829) compared to
controls (431765), it was evident that the patient cells were not
scattered but restricted to only certain regions of the UMAP
embedding (Figure 3A). This indicates that certain cell
populations are almost completely lacking in AT patients,
while others are still present. Density plots of the individual
samples indicated that there were still clear differences in
distribution of naive T cells between the individual control and
individual patient samples (Figure 3B). A selection of markers of
which the expression is colored on the UMAP of all samples is
shown in Figure 3C. The complete set of markers of controls and
AT patients is shown in Figures S5A and S5B, respectively.
To quantify these observations, we defined 5 regions in the
UMAP embedding, guided by the density plots and the
expression of the parameters: CD31+CD45RA++CCR7++
(Reg ion 1) , CD31 -CD45RA++CCR7++ (Reg ion 2) ,
CCR7+CD95+ (Region 3), CD25+ (Region 4) and CD127++
cells (Region 5) (Figure 3C). As previously reported, the




FIGURE 2 | Atypical CD45RAdimCCR7+ population in two samples of classic AT patients. (A) CD4 T cells from classic AT1 showing a large atypical population
(86%) which is visualized by the red gate on top of the differentiation subset gates. (B) CD8 T cells from classic AT5 showing a large atypical population (76%) which
is visualized by the red rectangular gate on top of the differentiation subset gates. (C) Heatmap of marker intensities [Mean Fluorescent Intensities (MFI; MIN (blue) –
MAX (red)] of the CD4+ atypical population and the differentiation subsets from sample AT1. (D) Similar to C, but for the CD8+ atypical population and the
differentiation subsets from sample AT5.
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significantly lower numbers in AT patients compared to healthy
controls (medians: 12 x 106 cells/L vs. 448 x 106 cells/L;
Figure 3D). Besides CCR7 and CD45RA, only CD27 and
CD28 were expressed on these cells (Figures 3C, E). The
CD31+ cells were also present in lower numbers in the control
samples C4 and C5, which are from older individuals, aged 37
and 59 years (Figure 3B). Region 2 contained naive cells that
were no longer expressing CD31 but were sharing (high)
expression of CCR7, CD45RA, CD27 and CD28 with cells
from region 1 (Figure 3C). 20% of the cells from patients and
controls expressed CD95 (Figure 3F). The absolute number of
CD31- cells from region 2 was also significantly lower in the AT
group compared to controls (Figure 3D). The CCR7+ cells in






FIGURE 3 | UMAP of naive CD4 T cells highlights lack of naive CD31+ Recent Thymic Emigrants and CD25+ naive T regulatory, but comparable numbers of stem
cell memory T cells. (A) UMAP plot of CD4 naive T cells, showing the cells of the classic AT patients (red; 72829 cells) positioned on top of controls (green; 431765
cells). (B) Individual UMAP density plots for each sample, on the top row controls and on the bottom row classic AT patients. (C) Fluorochrome intensities
superimposed on the UMAP embedding for a subset of markers (All markers shown in Figures S5A, B). Based on these marker intensities, the overlay in A and
individual sample plots in B, we defined 5 regions, as shown in the bottom-right plot: CD31+CD45RA++CCR7++ (Region 1), CD31-CD45RA++CCR7++ (Region 2),
CCR7+CD95+ (Region 3), CD25+ (Region 4) and CD127++ cells (Region 5). (D) Calculated absolute blood cell counts based on events within each region visualized
in bar graphs (median) and individual dots of the classic AT (red) and controls (green). (E–I) Bars graphs (median) and individual closed circles of the Classic AT (red)
and controls (green) showing the percentage of Boolean gating defined positive cells in each region. * means P < 0.05, and ** means P ≤ 0.01.
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CD45RA and CCR7 than cells in region 1 and by expression of
CD95 and CXCR3, markers associated with stem cell memory
cells (Figures 3C, G). DNAM1, TIGIT and PD1 were expressed
on 10-40% of the cells (Figure 3G). Interestingly, the absolute
cell numbers in patients were comparable to controls
(Figure 3D), except in one patient (AT1, Figure 3D). The
proportion of cells expressing each of the markers was also
comparable in region 3 between patients and controls, indicating
that there were no major differences in phenotypes (Figure 3G).
Region 4 was identified by a uniform expression of CD25 and
contained the regulatory T cell (Treg) population. The absolute
number of Treg cells was significantly higher in control samples
than in the patients (median: 20 x 106/L vs. 2 x 106/L;
Figure 3D). In the patients there were markedly fewer CD25+
cells expressing CD31 compared to controls (median: 17% vs.
51%) (Figure 3H). Moreover, higher percentages of cells
expressing CD95 in AT patients (median: 44% vs. 84%) and
TIGIT (median: 49% vs. 73%) were observed, indicating that, like
in the conventional naive T cells, there was a relative skewing
towards cells that had encountered antigen within the Tregs
(Figures 3C, E, H) (24). Region 5 was dominated by cells from 1
patient sample, AT5 (Figures 3B, D). These cells expressed
CD127, CD31, DNAM1, CD27, CD28 and partly CD95,
CXCR3 and CCR6 (Figures 3C, I).
We applied the same analysis to the naive CD8 T cells. Again,
a higher number of cells were analyzed from the controls (61945)
compared to the AT patients (24769). The patient and control
sample distribution over the UMAP embedding revealed both
control- and patient-specific regions (Figures 4A, B). A selection
of markers colored on the UMAP is shown in Figure 4C. The
complete set of markers of controls and AT patients is shown in
Figures S6A and S6B respectively. Five regions were assigned in
the UMAP of the naive CD8 T cells (Figure 4C);. Region 1
contained CCR7++CD45RA++ cells that expressed CD27, CD28
and CD31 [which is not a marker for recent thymic emigrants in
CD8 cells (25)] and were present in higher numbers in controls
than in patients (160 x 106 cells/L vs. 4 x 106 cells/L)
(Figures 4B–E). Region 2 was characterized by lower CCR7
expression and high percentages of CD95 and CXCR3 expressing
cells, two markers associated with stem cell memory T cells.
DNAM1 and TIGIT were expressed on 40-60% and CD244,
CD160, PD1 on 10-40% of the cells (Figure 4F). The absolute
numbers of the cells in region 2 in patients and controls were
equal (Figure 4D). Region 3 was phenotypically and
quantitatively similar to region 2 except that cells lacked CD31
expression (Figures 4D, G). This suggests that the stem cell
memory cell compartment has a normal size in AT patients. In
regions 1, 2 and 3 CD95, CXCR3, CCR6, TIGIT, DNAM1,
CD244, CD160 and PD1 were not differentially expressed
between the patients and controls (Figures 4E–G).
Regions 4 was dominated by cells from patient AT3
(Figure 4B). Cells in region 4 had a phenotype similar to cells
in region 1, except that all cells were CXCR3+ and more cells
were CD95+ (Figures 4E, H). Region 5 only contained cells from
patient AT5 and was characterized by CXCR3 expression and a
heterogenous expression of CD31, CD95, CCR6 and DNAM1
(Figure 4I). Together, these findings demonstrated that based on
CCR7, CD45RA, CD31, CD95, CXCR3, CCR6, DNAM1 and
TIGIT multiple naive T cell subsets were identified. Remarkably,
despite reduction in total naive CD8 T cells, T cells with a stem
cell memory phenotype were present in normal numbers in
AT patients.
Memory T Cell Phenotypes in AT Patients
Are as Heterogenous as in Controls
Because there were no differences in absolute numbers of CM,
EM and EMRA cells between patients and controls, the memory
T cells were analyzed as total non-naive T cells and visualized in
opt-SNE embeddings. In contrast to the naive CD4 T cells, the
memory CD4 T cells from both the patient and control groups
were evenly scattered (Figure 5A). The density plots depicting all
individual samples illustrated that the density of memory T cells
was equally distributed per sample (Figure 5B). The advantage
of opt-SNE is its power to accentuate phenotypically identical
cells by grouping of the cells. However, no distinct clusters were
revealed by the embedding. The CM, EM and EMRA
populations were not clearly separated based on CCR7 and
CD45RA (Figure 5C, complete set of Opt-SNE in S7A, B). We
did observe a CD25+CD127low Treg population and a CD27-
CD28- cluster at the top of the embedding (Figure 5C). The Treg
population was quantified in all samples and absolute numbers
of cells were equal in patients and controls (Figure 5D),
illustrating that also within the Treg population, there was only
a relative lack of naive cells. This CD27-CD28- cluster was further
defined by CD244, DNAM1 and a heterogenous expression of
CD45RA, CD45RO and CD57, indicating that memory subsets
are better defined based on CD27 and CD28, rather than
CD45RA and CCR7. The highest frequency of CD27-CD28-
CD4 T cells was observed in the controls C2, C3 and C5 that
were seropositive for CMV, but also in AT3 (CMV+) and AT5
(CMV serostatus unknown) (Table S1 and Figure 5E).
Since no distinct additional clusters were revealed, we decided
to calculate a diversity index, based on the Boolean gating of all
chemokine receptors, interleukin receptors, activating and
inhibitory receptors to reflect the phenotypical heterogeneity in
the CD4 memory compartment. In total more than 16000
possible phenotypes were defined, of which 1518 were
detected. The inversed Simpson index, reflecting diversity, is
based on the distribution of these phenotypes and revealed that
the diversity in controls (median 41.0) and AT patients (median
40.5) was comparable (Figure 5F). The most frequent phenotype
in all samples was CD27+CD28+DNAM1+CD57- with absence of
other activating and inhibitory receptors (Figure S8A).
Together, these findings indicated that the CD4 memory T cell
compartment of AT patients is as heterogenous as in the
control samples.
Also for the CD8 memory T cells we applied opt-SNE to
reveal phenotypically identical groups of cells. Again, no obvious
differences between distribution of memory cells in patient and
control samples was observed (Figures 6A, B; complete set in
S9A–B), except that we identified multiple sample specific
Weitering et al. T Cell Immunity in AT
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groups of cells. For instance, a CD127++CCR6+/-CD28++ subset
was only observed in C1, C3 and C4 (Figures 6B, C). In addition,
multiple sample specific clusters were observed in the CD28-
and/or CD27- memory CD8 T cells, which were further defined
based on CD56, CD57 and all activating and inhibitory
receptors, such as TIGIT, NKG2A and CD160. The CD27-
CD28- memory CD8 T cells were present at higher numbers in
C2, C3 and C5 (all CMV+ serostatus), but also in AT3 (CMV+)
and AT5 (CMV serostatus unknown) (Figure 6D) (26, 27). To
quantify all possible phenotypes based on the chemokine
receptors, interleukin receptors and activating/inhibitory
receptors, we again applied Boolean gating which revealed
3396 different phenotypes. The diversity index showed that the
median diversity was comparable between controls and patients
(Figure 6E). The CMV seropositive C2, C3, and C5 had the






FIGURE 4 | UMAP of naive CD8 T cells highlights reduced CD31+ cells, but comparable numbers of stem cell memory T cells. (A) UMAP plot of CD8 naive T cells,
showing the cells of the classic AT patients (red; 24769 cells) positioned on top of controls (green; 61945 cells). (B) Individual UMAP density plots for each sample,
on the top row controls and on the bottom row Classic AT. The density plots indicate clear differences in cell distributions between individual samples in both
groups. (C) Fluorochrome intensities superimposed on the UMAP embedding for a subset of markers (All markers shown in Figures S6A, B). Based on these
marker intensities, the overlay in A and individual sample plots in B, we defined 5 regions, as shown in the bottom-right plot: CCR7++ (Region 1), CCR7+CD95+
(Region 2), CCR7+CD95+CD31- (Region 3), AT3 Dominant (Region 4) and AT5 Dominant, or exclusive (Region 5). (D) Absolute counts of cells within each region,
visualized in bars graphs (median) and individual closed circles of the classic AT (red) and controls (green). (E–I) Bar graphs (median) and individual closed circles of
the classic AT (red) and controls (green) showing the percentage of Boolean gating defined positive cells in each region. * means P < 0.05.
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and 9.5% respectively) of the most frequent phenotype (CD27-
CD28-CD57+; Figure S8A). This is line with the high absolute
number of the CD27-CD28- CD8 T cells (Figure 6D). These
findings indicate that the diversity analysis is able to pick up
imbalances in the memory compartment. The spread in diversity
indices of samples of patients and controls was surprisingly
similar in both the CD4 and the CD8 memory T cells
(Figures 5F, 6E). In conclusion, the diversity of the memory T
cells in AT patients and controls was comparable.
DISCUSSION
In this study, we analyzed the T cell compartment of classic AT
patients in order to better understand why the severely reduced
naive T cell compartment does not prevent the formation and
maintenance of memory T cells and consequently does not lead
to opportunistic infections in the vast majority of patients. Until
now it was known that the naive T cells in AT patients were





FIGURE 5 | Opt-SNE and phenotypical diversity indices in the CD4 memory compartment reveals similar heterogeneity in classic AT and controls. (A) CD4 memory
T cells Opt-SNE plot, showing the cells of the classic AT (red) patients positioned on top of controls (green). (B) Individual Opt-SNE density plots for each sample, on
the top row controls and on the bottom row classic AT. (C) Fluorochrome intensities superimposed on the Opt-SNE embedding for a subset of markers (All markers
shown in Figures S7A, B). (D) Bar graphs (median) and individual closed circles of the classic AT (red) and controls (green) showing the calculated absolute blood
cell count of Boolean gating defined cells: CD25+CD127low regulatory T cells. (E) Idem for CD27-CD28- T cells. (F) The diversity or inversed Simpson index of the
CD4 memory T cells is shown as bars (median) and individual closed circles of the classic AT (red) and controls (green). The index was calculated based on the
Boolean gating of the following markers: CD28, CD27, DNAM1, CD57, CD244, CD56, PD1, CD160, TIGIT, NKG2A, CCR6, CXCR3, CCR7 and CD25. In total
16384 possible phenotypes were analyzed, of which 1518 were detected in the CD4 memory T cells.
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present in normal numbers. By investigating the expression of a
broad panel of markers associated with activation, differentiation
and ‘exhaustion’ of T cells, we present a detailed overview of both
the naive and the memory T cell compartment. Our main
conclusion based on this in-depth analysis is that the
composition of the memory compartment is phenotypically as
heterogeneous as that of healthy controls. This is in line with the
observation that AT patients do not have clinical symptoms
which can be attributed to T cell dysfunction. Regarding the
reduced naive T cell compartment, we confirmed that CD4+
recent thymic emigrants were reduced in absolute number as
well as in frequency. However, we identified in this naive
compartment a population of cells that is present in equal
numbers in AT patients and controls, which is a novel
observation in AT. These cells express CD95 and CXCR3
which is consistent with the phenotype of stem cell memory
cells, and we hypothesize that these stem cells are responsible for




FIGURE 6 | Opt-SNE and phenotypical diversity indices in the CD8 memory compartment reveals similar heterogeneity in classic AT and controls. (A) CD8 memory
T cells Opt-SNE plot, showing the cells of the classic AT (red) patients positioned on top of controls (green). (B) Individual Opt-SNE density plots for each sample, on
the top row controls and on the bottom row classic AT. (C) Fluorochrome intensities superimposed on the Opt-SNE embedding for a subset of markers (All markers
shown in Figures S8A, B). (D) Bars (median) and individual closed circles of the classic AT (red) and controls (green) showing the calculated absolute blood cell
count of Boolean gating defined CD27-CD28- T cells. (E) The diversity or inversed Simpson index of the CD8 memory T cells is shown as bars (median) and
individual closed circles of the classic AT (red) and controls (green) The index was calculated based on the Boolean gating of the following markers: CD28, CD27,
DNAM1, CD57, CD244, CD56, PD1, CD160, TIGIT, NKG2A, CCR6, CXCR3, CCR7 and CD25. In total 16384 possible phenotypes were analyzed, of which 3396
were present in the CD8 memory T cells.
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In 2 of the 5 samples of AT patients, AT1 and AT5, we
identified a dominant and homogenous atypical Tcell population
based on CCR7 and CD45RA expression. In preliminary
analyses using opt-SNE or UMAP, these cells are clearly
separated from the normal cells. It would be interesting to
follow up the development of such populations in longitudinal
samples and combine the analysis with cellular or molecular
Tcell receptor repertoire studies. These cells could be transiently
present as a result of dysregulation, or they may be oligoclonal
or even pre-malignant cells (34). Interestingly, these two
patients (AT1 and AT5) both completely lacked ATM protein
and were the most susceptible to bacterial infections within
our small cohort (Table S1). However, studies in mice show a
more severe phenotype for kinase-dead ATM, i.e. embryonic
lethality (35). The respective effects of ATM protein loss or
isolated loss of kinase activity on both the severity of
immunodeficiency and the development of these atypical T cell
expansions in human patients remains to be further studied in a
larger patient cohort.
It has been reported that AT patients have a severely reduced
naive T cell population in peripheral blood, containing low
TRECs, and few CD4 T cells expressing CD31 (12). Here we
confirmed these observations in the CD4 compartment. In this
regard the AT patients are reminiscent of aged healthy controls,
who also have a reduction in these population. However, the lack
of naive CD31+ T cells in AT patients appears more pronounced
than in our oldest control sample (59 years). Similarly, within
the naive CD4+CD25+ Treg population (Figure 3C; Region 4),
which was mostly lacking in AT patients, there is a relative
decrease in the proportion of cells expressing the naive marker
CD31. In contrast, the Treg cells within the memory
compartment, that are expressing CD95 and TIGIT, are still
present in AT patients in normal numbers. The observed lack of
the early (CD31+) naive conventional T cells appears to be
recapitulated in the composition of the Treg cells.
A surprising, novel finding was that a T cell subpopulation
within the naive CCR7+CD45RA+ gate expressed CD95 and
CXCR3. The CD95+ CD8 T cells also expressed and TIGIT (and
partially PD1) on a proportion of the cells. This population was
present in equal numbers in both controls and AT patients, in
contrast to the earlier naive T cell subpopulations, which were
severely reduced in AT. The combination of CD95 and CXCR3
has previously been reported to be expressed on stem cell
memory Tcells (30). More recently, the existence of CD8 stem
cell memory progenitor cells, expressing TIGIT and PD1 giving
rise to T cells with an ‘exhausted’ phenotype has been postulated
(36). Stem cell memory cells are antigen-experienced and
because of their self-renewal capacity they can persist for
decades (30). We hypothesize that the stem cell memory
population, consisting of more than one type of stem cell
memory cells, explains why these patients have an intact
memory T-cell compartment.
Detailed analysis of the memory T cell compartment in AT
did not reveal a more ‘exhausted’ phenotype in AT compared
to the controls analyzed, which could be expected in AT patients
based on similarity with another DNA repair disorder, the
Nijmegen Breakage syndrome (37). By assigning diversity
indices to the various samples, it became apparent that the
phenotypical variability was comparable between samples in
the control and classic AT group. By assigning diversity
indices, it became apparent that the phenotypical diversities
of classic AT patients were within the range of the controls.
This suggests that the memory T cells of AT patients
and controls were equally well equipped to respond to
antigenic challenges.
The observation that the memory T cells are indistinguishable
from healthy controls, is in line with the clinical observation that
AT patients, in general, do not seem to have immunological
complications, ascribed to T cell defects. Clearly, this study has
shown that the limited number of naive T cells in AT is sufficient
to mount adequate memory responses, and that the presence of
stem cell memory T cells may explain how these memory T cells
are maintained. This is highly relevant for better understanding
of T cell immunity in AT. Moreover, it provides possibilities for
further research on this recently identified T cell population in
other inborn errors of immunity.
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